EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Targeted Intracellular Copper Reservoir Enhances Liver Cancer Immunotherapy

Tianao Xie, Yukai Shan, Win Topatana, Taorui Yang, Ruijing Shen, Shijie Li, Jiadong Chen, Yiyuan Zhu, Ziyi Lu, Yeling Liu, Tianen Chen, Yujie Gao und 4 weitere

Small · 2025-09 · 21 (36)

DOI: 10.1002/smll.202502783 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 20.07.2025. Verfasst von Tianao Xie und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University, Hangzhou, 310016, P. R. China. Hauptthemen laut MEDLINE: Copper, Immunotherapy, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China, State Key Laboratory of Advanced Drug Delivery and Release Systems.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is commonly classified as a “cold tumor” due to its low immunogenicity and poor response to conventional immunotherapies. Reprogramming the tumor immune microenvironment (TIME) via cuproptosis presents a promising strategy to enhance immunotherapies. Herein, sono‐activatable N,N,N’,N’‐tetrakis(2‐pyridinylmethyl)‐1,2‐ethanediamine (TPEN)‐encapsulated cancer‐targeted nanoparticles (STCNs) designed to modulate the TIME and potentiate immunotherapy through endogenous cuproptosis are reported, termed “endogenous cuproptosis immunopromotion”. STCNs are rapidly internalized by HCC via folate‐mediated endocytosis, and ultrasound irradiation triggers the release of TPEN. TPEN then chelates Cu 2 ⁺ from superoxide dismutase, initiating a Fenton‐like reaction induced by glutathione that produces reactive oxygen species (ROS) and Cu⁺. This cascade induces cuproptosis and immunogenic cell death (ICD), promoting robust cytotoxic T lymphocyte infiltration in HCC. The combination of STCNs with anti‐programmed cell death protein 1 (PD1) therapy demonstrates significant anti‐tumor efficacy in vivo. Moreover, this strategy exhibits similar effectiveness in other solid tumor models, underscoring its broad therapeutic potential. These findings provide a promising framework for enhancing immunotherapy in cold tumors, paving the way for future cancer treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperImmunotherapyLiver NeoplasmsCarcinoma, HepatocellularAnimalsHumansMiceNanoparticlesCell Line, TumorReactive Oxygen SpeciesTumor Microenvironment

Stichwörter der Autor:innen

cuproptosishepatocellular carcinomaimmunogenic cell deathmetal‐organic frameworkssonodynamic therapy

Substanzen

CopperReactive Oxygen Species

Autor:innen und Institutionen

  • Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University, Hangzhou, 310016, P. R. China.
  • National Engineering Research Center of Innovation and Application of Minimally Invasive Instruments, Sir Run-Run Shaw Hospital, Zhejiang University, Hangzhou, 310016, P. R. China.
  • School of Medicine, Zhejiang University, Hangzhou, 310058, P. R. China.
  • College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, P. R. China.
  • Department of Chemistry, Zhejiang University, Hangzhou, 310016, P. R. China.
  • School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310058, P. R. China.

ORCID-Profile: Mingyu Chen

Förderung

  • National Natural Science Foundation of China
  • Zhejiang Provincial Natural Science Foundation of China
  • State Key Laboratory of Advanced Drug Delivery and Release Systems
  • Youth Development Fund Program of Sir Run Run Shaw Hospital
  • Zhejiang University School of Medicine

Zitieren

APA

Xie, T., Shan, Y., Topatana, W., Yang, T., Shen, R., Li, S., Chen, J., Zhu, Y., Lu, Z., Liu, Y., Chen, T., Gao, Y., Sun, Y., Cai, X., Juengpanich, S., & Chen, M. (2025). Targeted Intracellular Copper Reservoir Enhances Liver Cancer Immunotherapy. Small, 21(36). https://doi.org/10.1002/smll.202502783

Vancouver

Xie T, Shan Y, Topatana W, Yang T, Shen R, Li S, et al. Targeted Intracellular Copper Reservoir Enhances Liver Cancer Immunotherapy. Small. 2025;21(36). doi:10.1002/smll.202502783

BibTeX
@article{Xie2025,
  author = {Xie, Tianao and Shan, Yukai and Topatana, Win and Yang, Taorui and Shen, Ruijing and Li, Shijie and Chen, Jiadong and Zhu, Yiyuan and Lu, Ziyi and Liu, Yeling and Chen, Tianen and Gao, Yujie and Sun, Yuchao and Cai, Xiujun and Juengpanich, Sarun and Chen, Mingyu},
  title = {Targeted Intracellular Copper Reservoir Enhances Liver Cancer Immunotherapy},
  journal = {Small},
  year = {2025},
  volume = {21},
  number = {36},
  doi = {10.1002/smll.202502783}
}
Kostenlos starten →